Newsroom


Bioventus Announces Change in Chief Executive Officer, Ken Reali Appointed to Succeed Tony Bihl Who Will Retire

DURHAM, NC - March 25, 2020 – Tony Bihl, CEO of Bioventus, a global leader in orthobiologic solutions, is electing to retire on April 30, 2020. As a…

Read More

Bioventus Recognizes 25 Years of Bone Healing from Exogen

DURHAM, NC – February 24, 2020 – Bioventus, a global leader in orthobiologic solutions, is recognizing 25 years of proven bone healing with its…

Read More

Bioventus Updates US Label for EXOGEN Ultrasound Bone Healing System

DURHAM, NC – February 10, 2020 – Bioventus, a global leader in orthobiologic solutions, has updated the indications for use for its EXOGEN Ultrasound…

Read More

Bioventus to Provide Blue Cross Blue Shield of Michigan with Preferred Options for Knee Osteoarthritis Patients, Products include DUROLANE®, GELSYN-3® and SUPARTZ FX®

DURHAM, NC – December 18, 2019 – Beginning January 1, 2020 Bioventus, a global leader in orthobiologic solutions, has secured preferred access for…

Read More

Bioventus Launches OAKneePainRelief.com

DURHAM, NC – October 10, 2019 – In support of World Arthritis Day, which is celebrated every October 12 to raise awareness of arthritis, Bioventus, a…

Read More

National Institute for Health and Clinical Excellence Maintains Previous Recommendation for EXOGEN® Ultrasound Bone Healing System

HOOFDDORP, THE NETHERLANDS – October 8, 2019 – Bioventus, a global leader in orthobiologic solutions, has received notice from the United Kingdom’s…

Read More

Bioventus Agrees to Nationwide Contract with UnitedHealthcare® Commercial Plans, Members Have Access to DUROLANE® and GELSYN-3®for Knee Osteoarthritis

DURHAM, NC – September 9, 2019 – Bioventus, a global leader in orthobiologic solutions, has agreed to a nationwide contract with UnitedHealthcare…

Read More

Bioventus Launches DUROLANE® SJ (1mL) in Australia and New Zealand; Receives Expanded Indications for DUROLANE (3mL)

HOOFDDORP, THE NETHERLANDS – August 13, 2019 – Bioventus, a global leader in orthobiologic solutions, is launching DUROLANE SJ (1mL), and has…

Read More

Bioventus to Co-Develop Next Generation Placental Tissue Product for Knee Osteoarthritis with MTF Biologics

DURHAM– June 6, 2019 – Bioventus, a global leader in orthobiologic solutions, has entered into a development collaboration agreement with MTF…

Read More

Bioventus Launches OSTEOAMP SELECT Fibers

DURHAM, NC – March 27, 2019 – Bioventus, a global leader in orthobiologic solutions, is launching OSTEOAMP SELECT Fibers, an innovative addition to…

Read More

Search News


Media Inquiries


Thomas Hill
Director of Corporate Communications
919.474.6715
[email protected]

Download Library


Corporate and Brand Logos
Download Now

Product Images
Download Now